NO BENEFIT TO DAILY ASPIRIN IN HEALTHY OLDER PEOPLE

摘要

Daily low-dose aspirin does not increase the duration of disability-free life in healthy older people, trial results published in the New England Journal of Medicine (online, 16 September 2018) have shown. The study involved 19,114 people in the United States and Australia with a median age of 74 years who did not have cardiovascular disease, dementia or physical disability. Of these, 9,525 participants were randomly assigned to receive 100mg of enteric-coated aspirin daily and 9,589 participants to an oral placebo. Individuals were followed-up for a median of 4.7 years.